Letter to the editor: risk factors for cervical artery dissection - a systematic review with meta-analysis [0.03%]
写给编辑室：颈动脉夹层的风险因素-一项系统性回顾和荟萃分析
Joshua Plener,L Rachid Salmi,J David Cassidy et al.
Joshua Plener et al.
Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial [0.03%]
洛博拉米沙尔治疗急性缺血性卒中的多中心随机双盲平行对照三期临床试验（LAIS研究）
Shuya Li,Xuechun Wang,Baoyu Feng et al.
Shuya Li et al.
Background and objectives: Loberamisal, a novel agent that dissociates the post-synaptic density protein 95/neuronal nitric oxide synthase complex and potentiates the α2-containing γ-aminobutyric acid type A receptors, ...
Chinese expert consensus on the treatment and diagnosis of moyamoya disease and moyamoya syndrome (2024) [0.03%]
中国 moyamoya 病和 moyamoya 综合征诊断和治疗专家共识（2024）
Wei Ni,Jiabin Su,Yuchao Fei et al.
Wei Ni et al.
Aim: Moyamoya disease (MMD) is a chronic, occlusive cerebrovascular disorder with no unified management guidelines. This consensus aims to provide updated, evidence-based recommendations for the diagnosis and treatment of...
Burden of stroke and its subtypes in young adults in Asia, 1990-2021: risk factors and future predictions [0.03%]
1990年至2021年亚洲年轻人卒中及其亚型的疾病负担：危险因素及未来预测
Wenbo Li,Qirui Guo,Cong Gao et al.
Wenbo Li et al.
Stroke remains a major global public health challenge, with persistent disparities in its burden across countries, and an increasing burden among young adults aged 15-49 has emerged as a growing concern. However, comprehensive evaluations o...
Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke [0.03%]
严重卒中患者检测循环中的胶质纤维酸性蛋白的临床价值
Megan Gjordeni,Jakob Pansell,Eric P Thelin et al.
Megan Gjordeni et al.
Stroke is a global health concern, requiring early and accurate diagnosis for effective treatment. Differentiating between ischaemic stroke and haemorrhagic stroke is critical, as treatment strategies differ significantly. While neuroimagin...
Chemical Optimization of Cerebral Embolectomy 2 (CHOICE 2) trial: study protocol [0.03%]
脑动脉取栓化学优化研究（CHOICE 2）试验方案
Arturo Renú,Patricia de la Riva,Raquel Delgado-Mederos et al.
Arturo Renú et al.
Rationale: The potential value of rescue intra-arterial thrombolysis in patients with large vessel occlusion (LVO) stroke treated with mechanical thrombectomy (MT) remains to be validated in randomised trials. ...
Rationale and design of a PROBE trial comparing continuous enteral nutrition to time-restricted enteral nutrition in severe stroke [0.03%]
连续性肠内营养与限时肠内营养治疗重度卒中的方案和设计(PROBE试验)
Tao Yu,Guangzhi Shi,Zi Ye et al.
Tao Yu et al.
Background and purpose: Continuous enteral nutrition treatment is routinely provided in the intensive care unit (ICU) for patients with critically ill stroke and contributes to circadian rhythm disruption because a time-l...
Surgical interventions for patients with spontaneous intracerebral haemorrhage: a systematic review and network meta-analysis [0.03%]
自发性脑出血患者手术治疗的系统评价和网络meta分析
Haomiao Wang,Yuhang Yang,Dawei Zhao et al.
Haomiao Wang et al.
Background: Intracerebral haemorrhage (ICH) is a critical condition that leads to significant mortality or profound disability. Surgery serves as an important intervention that can save lives; however, the surgical techni...
Safety and Efficacy of Remote Ischaemic Conditioning for Acute Ischaemic Stroke Treated with Mechanical Thrombectomy (RECAST-MT): rationale and design [0.03%]
远程缺血性调理在急性缺血性卒中机械取栓治疗中的安全性和有效性（RECAST-MT）：研究的合理性与设计
Yongle Wang,Shuangfeng Huang,Lan Liu et al.
Yongle Wang et al.
Rationale: Adjunctive neuroprotection is a promising strategy for improving functional recovery in patients with acute ischaemic stroke (AIS) treated with mechanical thrombectomy (MT). Remote ischaemic conditioning (RIC) ...
Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial [0.03%]
注射洛博拉米萨尔治疗急性缺血性卒中的多中心随机双盲安慰剂对照Ⅱ期临床试验
Baoyu Feng,Hao Li,Shuhong Xu et al.
Baoyu Feng et al.
Background and aims: Loberamisal is a small-molecule agent that inhibits the nNOS-postsynaptic density protein 95 coupling and enhances α2-containing γ-aminobutyric acid type A receptor, which has been shown effective i...